GlycoMimetics
$3.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.04 (+1.39%) As of 3:55 PM EDT today
Why Robinhood?
You can buy or sell GlycoMimetics and other stocks, options, ETFs, and crypto commission-free!
About GLYC
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. Read More The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD. The listed name for GLYC is GlycoMimetics, Inc. Common Stock.
Employees
57
Headquarters
Rockville, Maryland
Founded
2003
Market Cap
155.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
316.98K
High Today
$3.30
Low Today
$3.18
Open Price
$3.26
Volume
183.04K
52 Week High
$6.72
52 Week Low
$1.82
Collections
GLYC Earnings
-$0.39
-$0.26
-$0.13
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, Pre-Market